Study on Improving COVID-19 Vaccination in Rheumatologic Disease

This study is looking at different ways to encourage people with autoimmune and inflammatory rheumatic diseases (AIRD) to get the updated COVID-19 vaccine. It's testing several approaches: videos with patient stories about COVID-19 vaccination, videos and brochures on good oral health, and phone calls from patient navigators to offer support and information about the vaccine. The study aims to see if these methods help more people get vaccinated. You might be able to join if you are an adult (18+) with AIRD, are Black and/or Latinx, and haven't received the updated COVID-19 vaccine. The study will measure how many participants get vaccinated after 3 months. The current status of the study is unclear, and it plans to enroll 1170 people.

Study design
This is an interventional study, meaning participants will receive specific interventions. It plans to enroll 1170 participants.
What's involved
Participants will watch videos, receive brochures, and some will receive phone calls from patient navigators. The study measures vaccination status at 3 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months to measure receipt of updated COVID-19 vaccination.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06469788

Testimonials and Navigation in Rheumatology

Recruiting
NAAges 18+InterventionalHealth services
University of Alabama at Birmingham
~1,170 participants
Updated 2026-05-06 on ClinicalTrials.gov
What's tested:Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiencesVideo on the importance of good oral health for patients with AIRDBrochure on COVID-19 vaccination in AIRD patientsPatient NavigationBrochure on the importance of good oral health in AIRD patients

At a glance

Recruiting sites
1 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Receipt of updated COVID-19 vaccination.
Measured over 3 months
Rheumatologic Disease
Autoimmune Diseases
3 sites across 2 states
Massachusetts2
Alabama1
  • Maria I Danila, MD, MSc, MSPH · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham
Mary A Wilkenson, Clinical Research Coordinator, BS
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults (18+ years) with known AIRD
Black race and/or Latinx ethnicity
Individuals who have not obtained the updated COVID-19 vaccine series (self-report)

Exclusion

Lack of access to phone
  • Receipt of updated COVID-19 vaccination.3 months

    We will measure rates of receipt of updated COVID-19 vaccination.